These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


121 related items for PubMed ID: 3750271

  • 1. A comparison of the antithrombotic and haemorrhagic effects of a low molecular weight heparin (LHN-1) and conventional heparin.
    Diness V, Nielsen JI, Pedersen PC, Wolffbrandt KH, Ostergaard PB.
    Thromb Haemost; 1986 Jun 30; 55(3):410-4. PubMed ID: 3750271
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Antithrombotic activity of dermatan sulphates, heparins and their combination in an animal model of arterial thrombosis.
    Iacoviello L, D'Adamo MC, Pawlak K, Polishchuck R, Wollny T, Buczko W, Donati MB.
    Thromb Haemost; 1996 Dec 30; 76(6):1102-7. PubMed ID: 8972038
    [Abstract] [Full Text] [Related]

  • 6. Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function.
    Himber J, Kirchhofer D, Riederer M, Tschopp TB, Steiner B, Roux SP.
    Thromb Haemost; 1997 Sep 30; 78(3):1142-9. PubMed ID: 9308768
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacological studies on the low molecular weight heparin derivative CY 216.
    Kaiser B, Kühnemuth G, Markwardt F.
    Pharmazie; 1990 Jul 30; 45(7):522-4. PubMed ID: 2173004
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low affinity heparin is an antithrombotic agent.
    Gray E, Cesmeli S, Lormeau JC, Davies AB, Lane DA.
    Thromb Haemost; 1994 Feb 30; 71(2):203-7. PubMed ID: 8191399
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Studies on the antithrombotic effects and pharmacokinetics of heparin fractions and fragments.
    Fareed J, Walenga JM, Williamson K, Emanuele RM, Kumar A, Hoppensteadt DA.
    Semin Thromb Hemost; 1985 Jan 30; 11(1):56-74. PubMed ID: 3883500
    [Abstract] [Full Text] [Related]

  • 17. Antithrombotic and haemorrhagic effects of the naturally occurring thrombin inhibitor hirudin.
    Kaiser B, Markwardt F.
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988 Jan 30; 115(1-2):41-6. PubMed ID: 2459030
    [Abstract] [Full Text] [Related]

  • 18. Nonpeptide factor Xa inhibitors III: effects of DPC423, an orally-active pyrazole antithrombotic agent, on arterial thrombosis in rabbits.
    Wong PC, Crain EJ, Watson CA, Zaspel AM, Wright MR, Lam PY, Pinto DJ, Wexler RR, Knabb RM.
    J Pharmacol Exp Ther; 2002 Dec 30; 303(3):993-1000. PubMed ID: 12438519
    [Abstract] [Full Text] [Related]

  • 19. Comparison of a low-molecular-weight heparin (nadroparin calcium) and unfractionated heparin as adjunct to coronary thrombolysis with alteplase and aspirin in dogs.
    Jun L, Arnout J, Vanhove P, Dol F, Lormeau JC, Herbert JM, Collen D, Van de Werf F.
    Coron Artery Dis; 1995 Mar 30; 6(3):257-63. PubMed ID: 7788040
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.